Predictive methods based on alpha-1-acid glycoprotein levels
CA 2357008 A1 · Owner: Bruno, Rene · Inventors: Bruno, Rene
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for determining the dosage of a taxoid to administer to a patient who is being treated for cancer and whose body fluids include alpha-1-acid glycoprotein comprising observing the patient's level of alpha-1-acid glycoprotein, evaluating said level to determine the dosage of the taxoid to administer to the patient by comparing said level to a predetermined alpha-1acid glycoprotein level derived from a population of patients having said cancer and treated with said taxoid at a common dosage and based on said evaluation, recommending the dosage of the taxoid to administer to the patient. Also, a method for assessing the effect of treatment of a patient who has cancer and who is …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 30, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 30, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 30, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.